Doc,
Is your time estimate below still the same?
“
Patients are observed for 30 more days as part of the protocol, so the study should be complete 6/27/19 +/- 1-3 days. Study completion should get a PR the next day so we should know for certain by 6/28/19 or 7/1/2019 at the latest. Topline release should be 6-10 weeks later, 8/8/19 to 9/5/19.”
Did the July 15 PR change anything?
NEW YORK, July 15, 2019 /PRNewswire/ -- NeurotropeInc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that the Company has concluded data collection in its confirmatory Phase 2 double blind, placebo controlled clinical trial of Bryostatin-1 in the treatment of moderately severe to severe AD.
Thanks
Market Data 
Markets 
AI
